Safety, efficacy, and cost-effectiveness of intraoperative blood salvage in OPCABG with different amount of bleeding: A single-center, retrospective study

Journal of Cardiothoracic Surgery

Volumn 13, Issue 1, 2018, Pages

  Wang, Huan ^a   Zheng, Weijian ^a   Fang, Weiping ^a   Meng, Gaige ^a   Zhang, Lei ^a   Zhou, Yannan ^a   Gu, Erwei ^a   Liu, Xuesheng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Autologous blood transfusion; Cost effectiveness; OPCABG

Indexed keywords

AGED; BLOOD SALVAGE; BLOOD TRANSFUSION; CHINA; COST BENEFIT ANALYSIS; ECONOMICS; ERYTHROCYTE TRANSFUSION; EVALUATION STUDY; FEMALE; HEALTH CARE COST; HUMAN; MALE; MIDDLE AGED; OFF PUMP CORONARY SURGERY; OPERATIVE BLOOD LOSS; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHINA; CORONARY ARTERY BYPASS, OFF-PUMP; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; RETROSPECTIVE STUDIES;

EID: 85055079892     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/s13019-018-0794-6     Document Type: Article

References (23)

1. Malhotra A, Garg P, Bishnoi AK, Sharma P, Wadhawa V, Shah K, et al. Dialyzer-based cell salvage system: a superior alternative to conventional cell salvage in off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2017;24(4):489-97.
2. Mehr-Aein A, Sadeghi M, Madani-civi M. Does tranexamic acid reduce blood loss in off-pump coronary artery bypass? Asian Cardiovasc ThoracAnn. 2007;15(4):285-9.
3. Dai Z, Chu H, Wang S, Liang Y. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: a systematic review and cumulative meta-analysis. J Clin Anesth. 2018;44:23-31.
4. Shafiee A, Nazari S, Mogharreban M, Koupaei MT. Evaluating medical interns' knowledge of common blood transfusion complications. Transfus Apher Sci. 2013;48(2):253-6.
5. Hassall O, Maitland K, Pole L, Mwarumba S, Denje D, Wambua K, et al. Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital. Transfusion. 2009;49(12):2594-8.
6. Sulu B, Aytac E, Stocchi L, Vogel JD, Kiran RP. The minimally invasive approach is associated with reduced perioperative thromboembolic and bleeding complications for patients receiving preoperative chronic oral anticoagulant therapy who undergo colorectal surgery. Surg Endosc. 2013;27(4):1339-45.
7. Weltert L, Nardella S, Rondinelli MB, Pierelli L, De Paulis R. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison. Transfusion. 2013;53(4):790-7.
8. ATLS Subcommittee, American College of Surgeons' Committee on Trauma, International ATLS working group. Advanced trauma life support (ATLS(R)): the ninth edition. J Trauma Acute Care Surg. 2013;74(5):1363-6.
9. Vonk AB, Meesters MI, Garnier RP, Romijn JW, van Barneveld LJ, Heymans MW, et al. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study. Transfusion. 2013;53(11):2782-9.
10. Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M, et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation. 2007;116(17):1888-95.
11. Mutneja HR, Arora S, Vij A. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;373(2):190.
12. Karkouti K, Stukel TA, Beattie WS, Elsaadany S, Li P, Berger R, et al. Relationship of erythrocyte transfusion with short- and long-term mortality in a population-based surgical cohort. Anesthesiology. 2012;117(6):1175-83.
13. Feng S, Machina M, Beattie WS. Influence of anaemia and red blood cell transfusion on mortality in high cardiac risk patients undergoing major non-cardiac surgery: a retrospective cohort study. Br J Anaesth. 2017;118(6):843-51.
14. Schwann TA, Habib JR, Khalifeh JM, Nauffal V, Bonnell M, Clancy C, et al. Effects of blood transfusion on cause-specific late mortality after coronary artery bypass grafting-less is more. Ann Thorac Surg. 2016;102(2):465-73.
15. Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, et al. Restrictive or Liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377(22):2133-44.
16. Shen S, Zhang J, Wang W, Zheng J, Xie Y. Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. J Transl Med. 2016;14(1):228.
17. Buys WF, Buys M, Levin AI. Reinfusate heparin concentrations produced by two autotransfusion systems. J Cardiothorac Vasc Anesth. 2016;31(1):90-98.
18. Cui B, Zhao P, Wang C. The different influence of inflammatory response after transfusion with autologous blood and stored blood. J Clin Anesthesiol. 2015;31(3):247-9.
19. Paladino L, Subramanian RA, Bonilla E, Sinert RH. Leukocytosis as prognostic indicator of major injury. West J Emerg Med. 2010;11(5):450-5.
20. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg. 1996;112(2):494-500.
21. Xie Y, Shen S, Zhang J, Wang W, Zheng J. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. Int J Med Sci. 2015;12(4):322-8.
22. Attaran S, McIlroy D, Fabri BM, Pullan MD. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases. Interact Cardiovasc Thorac Surg. 2011;12(5):824-6.
23. Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg. 2009;109(2):320-30.